Quick Answer
VOLITIONRX LTD reported Research And Development Expense of $10.08 million for the year ending 2025.
- VOLITIONRX LTD showed a decrease of -30.0% in Research And Development Expense from 2024 to 2025.
- This data is from VOLITIONRX LTD's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $511.0 thousand | Q2 2012: $559.4 thousand | Q3 2012: $633.8 thousand | Q1 2013: $593.2 thousand | Q2 2013: $640.6 thousand | Q3 2013: $524.5 thousand | Q1 2014: $870.5 thousand | Q2 2014: $791.3 thousand | Q3 2014: $1.07 million | Q1 2015: $1.21 million | Q2 2015: $1.36 million | Q3 2015: $1.86 million | Q1 2016: $1.46 million | Q2 2016: $1.75 million | Q3 2016: $1.97 million | Q1 2017: $1.67 million | Q2 2017: $1.81 million | Q3 2017: $2.13 million | Q1 2018: $2.42 million | Q2 2018: $2.69 million | Q3 2018: $2.74 million | Q1 2019: $2.47 million | Q2 2019: $2.48 million | Q3 2019: $2.64 million | Q1 2020: $3.89 million | Q2 2020: $3.49 million | Q3 2020: $3.18 million | Q1 2021: $3.87 million | Q2 2021: $2.94 million | Q3 2021: $3.61 million | Q1 2022: $3.59 million | Q2 2022: $3.28 million | Q3 2022: $4.00 million | Q1 2023: $4.91 million | Q2 2023: $5.45 million | Q3 2023: $4.65 million | Q1 2024: $4.63 million | Q2 2024: $3.72 million | Q3 2024: $3.47 million | Q1 2025: $2.61 million | Q2 2025: $2.72 million | Q3 2025: $2.29 million.
- Over the full 15 years of available data (2011 to 2025), VOLITIONRX LTD's Research And Development Expense has grown by 562.8%.
- Historical annual values: Fiscal year 2025: $10.08 million | Fiscal year 2024: $14.41 million | Fiscal year 2023: $19.55 million | Fiscal year 2022: $15.33 million | Fiscal year 2021: $13.02 million | Fiscal year 2020: $14.53 million | Fiscal year 2019: $10.36 million | Fiscal year 2018: $10.91 million | Fiscal year 2017: $8.03 million | Fiscal year 2016: $7.90 million | Fiscal year 2015: $6.10 million | Fiscal year 2014: $4.04 million | Fiscal year 2013: $2.50 million | Fiscal year 2012: $2.77 million | Fiscal year 2011: $1.52 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: